Crossref
Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year
JAMA · 24.02.2026 · 335 (8) · 653
DOI: 10.1001/jama.2026.0287 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 24.02.2026. Verfasst von Rita Rubin. Beteiligte Einrichtung: Lead Senior Staff Writer, Medical News, JAMA. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
This Medical News article discusses clinical trial data for weight-loss medications, in both injectable and pill formations, that are currently under review with US Food and Drug Administration.
Autor:innen und Institutionen
- Lead Senior Staff Writer, Medical News, JAMA.
Zitieren
APA
Rubin, R. (2026). Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year. JAMA, 335(8), 653. https://doi.org/10.1001/jama.2026.0287
Vancouver
Rubin R. Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year. JAMA. 2026;335(8):653. doi:10.1001/jama.2026.0287
BibTeX
@article{Rubin2026,
author = {Rubin, Rita},
title = {Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year},
journal = {JAMA},
year = {2026},
volume = {335},
number = {8},
pages = {653},
doi = {10.1001/jama.2026.0287}
}
EUVIMED